ARS Pharmaceuticals, Inc. (SPRY) operating margin

Operating margin · fiscal 2025
-212.9%

ARS Pharmaceuticals, Inc. (SPRY) had an operating margin of -212.9% in fiscal 2025 (the year ended December 31, 2025). That is 209.5 percentage points lower than the -3.5% of fiscal 2024. Figures as of 17 Nov 2026, 18:02 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Operating margin, fiscal 2025
-212.9%
Change on fiscal 2024
−209.5 pts
Highest on record
-3.5%fiscal 2024
Lowest on record
-225066.7%fiscal 2023
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

ARS Pharmaceuticals, Inc. operating margin, in more detail

Across the 5 fiscal years on record (2021–2025), the highest was -3.5% in fiscal 2024 and the lowest -225066.7% in fiscal 2023. The fiscal 2025 figure is higher than in 75% of the 4 earlier fiscal years on record, whose median is -1526.1%.

Gross margin was 75.8% in fiscal 2025. Net margin was -203.3% in fiscal 2025.

History · 5 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Gross margin
  • Net margin

ARS Pharmaceuticals, Inc. operating margin, year by year

ARS Pharmaceuticals, Inc. (SPRY) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedGross marginNet margin
2025-212.9% 209.5 pts down75.8%-203.3%
2024-3.5% 225063.2 pts up98.9%9.0%
2023-225066.7% 222367.9 pts down100.0%-181216.7%
2022-2698.8% 2345.5 pts down—-2635.4%
2021-353.3%——-367.7%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

More on SPRY

ARS Pharmaceuticals, Inc., figure by figure

ARS Pharmaceuticals, Inc. (SPRY) overview: price, valuation and scorecard

ARS Pharmaceuticals, Inc. operating margin: questions and answers

What is ARS Pharmaceuticals, Inc.'s operating margin?

ARS Pharmaceuticals, Inc. (SPRY) had an operating margin of -212.9% in fiscal 2025 (the year ended December 31, 2025). That is 209.5 percentage points lower than the -3.5% of fiscal 2024.

Is ARS Pharmaceuticals, Inc.'s operating margin high or low compared with its own history?

The fiscal 2025 figure is higher than in 75% of the 4 earlier fiscal years on record, whose median is -1526.1%.

What are the highest and lowest operating margin figures on record for ARS Pharmaceuticals, Inc.?

Across the 5 fiscal years on record (2021–2025), the highest was -3.5% in fiscal 2024 and the lowest -225066.7% in fiscal 2023.

What are ARS Pharmaceuticals, Inc.'s gross and net margins?

Gross margin was 75.8% in fiscal 2025. Net margin was -203.3% in fiscal 2025.

How is ARS Pharmaceuticals, Inc.'s operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ARS Pharmaceuticals, Inc. (SPRY) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/SPRY/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.